Head-to-Head: which new heart valve works best?
NCT ID NCT06470022
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study compares two newer heart valve devices (Evolut FX and Sapien 3 Ultra Resilia) in people with aortic stenosis, a condition where the heart's main valve narrows. About 1,346 participants will be randomly assigned to receive one of the valves. The main goal is to see if one device is better at preventing death, stroke, valve leakage, or valve damage over the first year, with follow-up lasting up to 10 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of cardiology, Aarhus University Hospital
RECRUITINGAarhus, 8200, Denmark
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.